A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 24,806 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification date between 1 January and 31 March 2002 (Table 2). The notification rate of diseases per 100,000 population for each State or Territory is presented in Table 3.
Table 3. Notification rates of diseases by State or Territory, 1 January to 31 March 2002 (Rate per 100,000 population)
Disease1 |
State or Territory | Australia | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | ||
| Bloodborne diseases | |||||||||
| Hepatitis B (incident) | 0.0 |
0.9 |
4.0 |
1.3 |
0.8 |
4.3 |
2.9 |
2.3 |
1.7 |
| Hepatitis B (unspecified) | 22.9 |
40.1 |
NN |
20.0 |
10.4 |
8.5 |
36.6 |
20.0 |
30.0 |
| Hepatitis C (incident) | 2.5 |
1.3 |
0.0 |
NN |
2.4 |
0.9 |
1.2 |
6.7 |
2.0 |
| Hepatitis C (unspecified) | 61.1 |
56.8 |
84.8 |
84.9 |
34.8 |
91.9 |
96.4 |
41.9 |
70.0 |
| Hepatitis D | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Gastrointestinal diseases | |||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacteriosis2 | 120.9 |
_ |
103.0 |
104.2 |
166.5 |
160.0 |
101.9 |
115.4 |
114.8 |
| Cryptosporidiosis | 26.7 |
8.3 |
218.2 |
179.4 |
8.8 |
6.0 |
7.0 |
14.6 |
43.1 |
| Haemolytic uraemic syndrome | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Hepatitis A | 3.8 |
3.1 |
18.2 |
3.2 |
0.8 |
1.7 |
2.8 |
1.5 |
2.8 |
| Hepatitis E | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.9 |
0.0 |
0.0 |
0.0 |
| Listeriosis | 0.0 |
0.1 |
0.0 |
0.5 |
0.0 |
0.0 |
0.2 |
1.0 |
0.3 |
| Salmonellosis | 44.6 |
41.7 |
258.6 |
118.2 |
34.8 |
52.8 |
33.4 |
51.3 |
56.9 |
| Shigellosis | 0.0 |
0.8 |
66.7 |
2.4 |
3.2 |
0.0 |
1.3 |
8.3 |
2.8 |
| SLTEC,VTEC3 | 0.0 |
0.0 |
0.0 |
0.1 |
3.2 |
0.0 |
0.0 |
0.6 |
0.3 |
| Typhoid | 0.0 |
0.5 |
0.0 |
0.5 |
0.3 |
0.0 |
0.8 |
0.8 |
0.6 |
| Quarantinable diseases | |||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.0 |
0.3 |
0.0 |
0.0 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Sexually transmissible diseases | |||||||||
| Chlamydial infection | 159.1 |
65.2 |
577.8 |
164.1 |
101.9 |
93.6 |
99.1 |
155.5 |
111.4 |
| Donovanosis | 0.0 |
0.0 |
10.1 |
0.3 |
NN |
0.0 |
0.0 |
0.0 |
0.2 |
| Gonococcal infection4 | 5.1 |
18.9 |
753.5 |
26.1 |
5.6 |
4.3 |
16.0 |
69.7 |
30.5 |
| Syphilis5 | 5.1 |
5.9 |
181.8 |
2.2 |
0.8 |
2.6 |
0.1 |
8.3 |
5.3 |
| Vaccine preventable diseases | |||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.2 |
2.0 |
0.3 |
0.3 |
0.0 |
0.2 |
0.0 |
0.2 |
| Influenza | 1.3 |
0.7 |
8.1 |
2.6 |
1.1 |
0.0 |
3.6 |
4.2 |
2.2 |
| Measles | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.4 |
0.0 |
0.2 |
| Mumps | 0.0 |
0.3 |
0.0 |
0.2 |
0.3 |
0.0 |
0.5 |
0.4 |
0.3 |
| Pertussis | 19.1 |
30.8 |
58.6 |
60.9 |
48.7 |
18.7 |
19.1 |
17.7 |
33.5 |
| Pneumococcal disease | 0.0 |
4.7 |
22.2 |
3.6 |
4.0 |
5.1 |
5.0 |
8.1 |
5.0 |
| Poliomyelitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rubella6 | 0.0 |
0.4 |
2.0 |
3.7 |
0.5 |
0.0 |
0.6 |
0.4 |
1.1 |
| Tetanus | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.2 |
0.0 |
| Vectorborne diseases | |||||||||
| Arbovirus infection NEC | 0.0 |
0.2 |
0.0 |
0.3 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
| Barmah Forest virus infection | 0.0 |
3.8 |
24.2 |
13.6 |
0.8 |
0.0 |
3.0 |
2.7 |
5.2 |
| Dengue | 1.3 |
0.9 |
36.4 |
2.6 |
0.5 |
1.7 |
0.6 |
0.8 |
1.5 |
| Japanese encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus infection | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Malaria | 3.8 |
2.4 |
16.2 |
6.3 |
0.3 |
1.7 |
1.6 |
2.5 |
2.9 |
| Murray Valley encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.6 |
0.1 |
| Ross River virus infection | 0.0 |
2.4 |
64.6 |
46.9 |
6.1 |
31.5 |
0.7 |
11.5 |
12.8 |
| Zoonoses | |||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
NN |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.0 |
0.0 |
1.4 |
0.0 |
0.0 |
0.0 |
0.0 |
0.3 |
| Leptospirosis | 0.0 |
0.7 |
2.0 |
4.9 |
0.0 |
0.0 |
0.3 |
0.2 |
1.3 |
| Other lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ornithosis | 0.0 |
0.2 |
0.0 |
0.2 |
0.5 |
0.0 |
0.4 |
0.2 |
0.3 |
| Q fever | 0.0 |
3.1 |
2.0 |
9.6 |
0.5 |
0.0 |
0.9 |
1.3 |
3.3 |
| Other bacterial infections | |||||||||
| Legionellosis | 0.0 |
0.9 |
0.0 |
0.5 |
1.9 |
0.0 |
1.8 |
1.3 |
1.1 |
| Leprosy | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.2 |
0.0 |
| Meningococcal infection | 5.1 |
2.0 |
4.0 |
2.2 |
2.1 |
3.4 |
2.9 |
1.9 |
2.3 |
| Tuberculosis | 1.3 |
4.6 |
4.0 |
1.0 |
2.9 |
0.0 |
5.2 |
2.7 |
3.6 |
1. Rates are subject to retrospective revision.
2. Not reported for New South Wales because it is only notifiable as 'foodborne disease' or 'gastroenteritis in an institution'.
3. Infections with Shiga-like toxin (verotoxin) producing E. coli (SLTEC/VTEC).
4. Northern Territory, Queensland, South Australia , Victoria and Western Australia: includes gonococcal neonatal ophthalmia.
5. Includes congenital syphilis.
6. Includes congenital rubella.
NN Not Notifiable
NEC Not Elsewhere Classified.
- Elsewhere Classified.
The NNDSS is conducted under the auspices of the Communicable Diseases Network Australia. The system provides the national surveillance of more than 50 communicable diseases or disease groups endorsed by the Communicable Diseases Network Australia and the National Public Health Partnership. Notifications of these diseases are made to State and Territory health authorities under the provisions of their respective public health legislation. De-identified core unit data are supplied fortnightly for collation, analysis and dissemination. For further information, see Commun Dis Intell 2002;26:58.
This article was published in Communicable Diseases Intelligence Volume 26, No 2, June 2002
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 26, No 2, June 2002
Communicable Diseases Intelligence